{"id":229795,"date":"2024-09-04T13:26:47","date_gmt":"2024-09-04T13:26:47","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=229795"},"modified":"2024-09-04T13:26:47","modified_gmt":"2024-09-04T13:26:47","slug":"100-cele-mai-puternice-femei-din-business-simona-cocos-director-general-zentiva-romania-si-moldova-grupul-de-companii-zentiva-in-romania","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=229795","title":{"rendered":"100 Cele mai puternice femei din business. Simona Coco\u015f, Director general, Zentiva Rom\u00e2nia \u015fi Moldova, grupul de companii Zentiva \u00een Rom\u00e2nia"},"content":{"rendered":"<p style=\"text-align: center;\">\n<strong>Cifr\u0103 de afaceri (2023): 1,528 mld. lei<\/strong><\/p>\n<p style=\"text-align: center;\">\n<strong>Profit net: 282,5 mil. lei<\/strong><\/p>\n<p style=\"text-align: center;\">\n<strong>Num\u0103r de angaja\u0163i: 1.300<\/strong><\/p>\n<p>\n<em>*Cifrele se refer\u0103 la \u00eentreg grupul de companii Zentiva \u00een Rom\u00e2nia \u015fi sunt calculate pe baza situa\u0163iilor financiare preliminare, neauditate.<\/em><\/p>\n<hr \/>\n<p>\n<strong>Biografie: <\/strong>Simona Coco\u015f este directorul general al Zentiva, unul dintre cei mai mari produc\u0103tori de medicamente din Rom\u00e2nia. A absolvit Facultatea de Chimie, specialitatea inginerie chimic\u0103, \u015fi de\u0163ine un MBA \u00een management \u015fi strategie. Activeaz\u0103 \u00een domeniul farma din 1995, perioad\u0103 pe parcursul c\u0103reia a de\u0163inut diverse func\u0163ii \u00een v\u00e2nz\u0103ri \u015fi marketing, precum \u015fi pozi\u0163ii regionale \u00een cadrul Zentiva. Din 2009 este director general al Zentiva Rom\u00e2nia \u015fi Moldova.<\/p>\n<hr \/>\n<p>\n<img decoding=\"async\" alt=\"\" src=\"http:\/\/storage0.dms.mpinteractiv.ro\/media\/401\/341\/5846\/22460339\/91\/20-de-ani.jpg?height=235&#038;width=150\" style=\"width: 150px; height: 235px; margin: 10px; float: left;\" \/>\u25ba Acum 20 de ani \u00eemi doream s\u0103&nbsp; \u00eenv\u0103\u0163 c\u00e2t mai mult. \u00cenc\u0103 erau \u00eenceputurile de formare \u015fi profesionalizare a industriei pharma, lucram \u00eentr-o corpora\u0163ie cu sisteme \u015fi procese \u015fi \u00eentr-o pia\u0163\u0103 neomogen\u0103. Doream s\u0103 s\u0163iu c\u00e2t mai multe, s\u0103 fac multe, era foarte mult\u0103 efervescen\u0163\u0103 a cre\u015fterii personale \u015fi a descoperirii. Nu \u0163inteam nep\u0103rat o pozi\u0163ie sau un nivel profesional, voiam s\u0103 acumulez \u015fi m\u0103 bucuram de tot ce se mi se \u00eent\u00e2mpla profesional.<\/p>\n<p>\n\u25ba Realitatea de azi este la fel de frumoas\u0103 pentru mine. \u00cenv\u0103\u0163area este continu\u0103 pentru c\u0103 lumea se schimb\u0103. Am o alt\u0103 pozi\u0163ie acum \u015fi alte responsabilit\u0103\u0163i, dar \u015fi contextul este altul. Medicina \u015fi industria au evoluat, lumea evolueaz\u0103 \u015fi are alte nevoi, colegii no\u015ftri mai tineri au o alt\u0103 perspectiv\u0103, contextul extern organiza\u0163iei te pune \u00een fa\u0163a a nenum\u0103rate surprize, nu neap\u0103rat pozitive. Cele mai importante sentimente pe care le am sunt: al satisfac\u0163iei de a \u00eenv\u0103\u0163a, de adaptare \u015fi de \u00eencredere \u00een for\u0163ele proprii \u015fi ale echipei, de fiecare dat\u0103 c\u00e2nd trecem cu bine peste situa\u0163ii complexe sau dificile.&nbsp; \u00cens\u0103 cea mai important\u0103 schimbare fa\u0163\u0103 de acum 20 de ani este prezen\u0163a valorilor \u00eentr-un mod total diferit \u00een deciziile \u015fi rela\u0163iile din interiorul organiza\u0163iei \u015fi fa\u0163\u0103 de lumea din care facem parte.<\/p>\n<p>\n\u25ba Ast\u0103zi vedem deja semne ale viitorului. Oamenii tr\u0103iesc mai mult \u015fi cu mai multe nevoi de \u00eengrijire, cu costuri mai mari, cu op\u0163iuni terapeutice personalizate. Evolu\u0163ia medical\u0103 \u015fi farmacologic\u0103 va fi probabil mai rapid\u0103 datorit\u0103 model\u0103rilor computerizate \u015fi ale inteligen\u0163ei artificiale. Temerea cea mai mare pe care o am sunt inegalit\u0103\u0163ile privind accesul la s\u0103n\u0103tate. Progresul medicinei este costisitor, suprapunerea mai multor afec\u0163iuni la pacien\u0163i care tr\u0103iesc mai mult pune presiune pe fondurile de s\u0103n\u0103tate. Nu ne putem imagina un viitor mai bun \u00een tratarea bolilor \u015fi cre\u015fterea calit\u0103\u0163ii vie\u0163ii f\u0103r\u0103 cre\u015fterea accesului la tratamente pentru to\u0163i sau c\u00e2t mai mul\u0163i pacien\u0163i.<\/p>\n<p>\n<br \/>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cifr\u0103 de afaceri (2023): 1,528 mld. lei Profit net: 282,5 mil. lei Num\u0103r de angaja\u0163i: 1.300 *Cifrele se refer\u0103 la \u00eentreg grupul de companii Zentiva \u00een Rom\u00e2nia \u015fi sunt calculate pe baza situa\u0163iilor financiare preliminare, neauditate. Biografie: Simona Coco\u015f este directorul general al Zentiva, unul dintre cei mai mari produc\u0103tori de medicamente din Rom\u00e2nia. A [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511,7228],"tags":[27301,47567,8769],"class_list":["post-229795","post","type-post","status-publish","format-standard","hentry","category-afaceri","category-industrie","tag-100-cele-mai-puternice-femei-din-business","tag-simona-cocos","tag-zentiva"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/229795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=229795"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/229795\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=229795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=229795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=229795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}